Well that's one way looking at it, I believe we wouldn't have lost all this time, screwed up several deals costing tons in litigation, note conversions , issuing stock. Probably would have been listed, solid NASDAQ listing/pps, institutional participation, plenty funding ......imo salary would be a non-issue ...prob be a raise after revenue results.
We don't know ....all we know is where we are today and I don't think that was the plan when we started CC's late 2018.
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links